Skip to main content
Fig. 8 | European Journal of Medical Research

Fig. 8

From: A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer

Fig. 8

Therapeutic response evaluation with the SRGs-related prognostic signature. A–F Drug sensitivity (IC50) of bortezomib (A), cisplatin (B), docetaxel (C), gemcitabine (D), paclitaxel (E), pazopanib (F), lapatinib (G), methotrexate (H), temsirolimus (I), MK2206 (J), SB590885 (K), and VX702 (L) in the high- (red) and low-risk groups (blue)

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us